COLLPLANT HOLDI / S (NASDAQ: CLGN) is one of 27 public companies in the "Surgical equipment and supplies" industry, but how does it compare to its peers? We will compare APPLIED DYLETSOL to similar businesses based on the strength of its dividend, analyst recommendations, valuation, institutional ownership, earnings, risk and profitability.
Internal and Institutional Ownership
58.0% of all "Surgical equipment and supplies" shares are owned by institutional investors. 10.3% of all "Surgical equipment and supplies" shares belong to other people. Strong organizational ownership is a sign that large money managers, hedge funds and endowments believe that a company has set aside for long-term growth.
This is a summary of current rates and approvals for CONTINUED ASSISTANT and peers, as stated by MarketBeat.com.
|Selling Degrees||Holding Rates||Degree Prices||Strong Buy Rates||Score Score|
|HOLDI / S COLLPLANT||0||0||0||0||Not applicable|
|HOLDI / S COLLPLANT Competitors||175||823||1452||73||2.56|
As a group, "Surgical equipment and supplies" companies have a possible 18.75% station. Given the probable HOLDI / S COLLPLANT peers, analysts believe strongly that SUPPORT METHODS have less favorable growth aspects than peers.
Earnings and Appreciation
This table compares accumulation rates, earnings per share and valuation of HOLDI / S COLLPLANT and peers.
|Gross Revenue||Net Income||Price / Earnings ratio|
|HOLDI / S COLLPLANT||$ 480,000.00||– $ 6.02 million||-2.49|
|HOLDI / S COLLPLANT Competitors||$ 1.39 billion||$ 210.14 million||21.35|
HOLDI / S COLLPLANT peers have revenues and higher earnings than HOLDI / S COLLPLANT. HOLDI / S COLLPLANT is trading on a lower price-to-earner and peer ratio, noting that it is currently more affordable than other companies in its industry.
This table compares COLLPLANOL Edges and the net edges of its peers, returns on equity and returns on assets.
|Margenni Net||Return on Equity||Return on Assets|
|HOLDI / S COLLPLANT||-552.97%||-80.17%||-41.81%|
|HOLDI / S COLLPLANT Competitors||-154.27%||-364.44%||-23.63%|
APPLIED FINANCIAL CONTACTS ARCHWILIANT FOR APPLIED SCHOOLS at 7 of the 8 factors compared.
Profile of the company HOLDI / FUNCTIONS
CollPlant Holdings Ltd., a regeneration medicine company, focuses on the development and trading of tissue repair products for three-dimensional bio-printing of tissues and organs, orthobiologics, and higher wound care markets in the United States, Canada and Europe. Its products are based on type I human golea, which is generated with proprietary plant based genetic engineering technology. The company's products include Vergenix STR, a soft tissue repair matrix intended for treating tendinopathy; Vergenix FG, a flood gel that fills wounds for the treatment of deep surgical incision and wounds, including diabetic ulcers, venous ulcers and pressures, burns, bed beds and other chronic wounds; and BioInks for 3D printing of tissues and organs. CollPlant Holdings Ltd and has a headquarters at Ness Ziona, Israel.
Receive News and Minutes for DOCUMENTARY DYLETIES Daily – Enter your email address below for a summary daily summary of the latest news ratings and analysts for HOLDI / S COLLPLANT and associated companies with the FREE daily email newsletter MarketBeat.com.